AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)

RecruitingNAAges 18 Years - 70 YearsAllGuangdong Provincial People's Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Psycho-Cardiological Disease studies the complex links between the cardiovascular system and emotions. The two diseases are now the focus of public health organizations, forming a vicious circle of mutual influence. Anxiety and depressive symptoms are three to four times more common in patients with cardiovascular disease than in the general population, and about 15 to 18 percent of patients with coronary heart disease also have major depression, while 25 to 30 percent show significant depressive symptoms. At least 20% of patients with chronic heart failure have some degree of depression. In addition, the probability of cardiovascular events is 2.5 times higher in patients with two hearts, the risk of recurrence of cardiovascular events is heightened, and is strongly associated with higher mortality. At present, the common treatment methods show different advantages and disadvantages, fo

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Diagnosed with depression/anxiety; 2. Continued use of SSris and SNris for six months prior to study start; 3. Aged between 18 and 70; 4. Confirmed cardiovascular disease (such as chronic stable coronary heart disease, heart failure, cardiomyopathy, arrhythmia, valvular heart disease, cardiac surgery, cardiac intervention, ischemia with non-obstructive coronary artery disease, etc.); 5. The patients voluntarily participated in the study, signed a written informed consent, and were willing to cooperate with the follow-up. Exclusion Criteria: 1. currently has mania or hypomania, or a history of bipolar disorder and any mental disorders (current and previous); 2. organic brain injury, etc., or serious non-cardiovascular system diseases (such as advanced cancer); 3. Unable to participate in sports training or have drug contraindications; 4. Current alcohol, drug abuse, drug use or suicidal intent; 5. Patients who were receiving other doses of eligible drugs and other antidepressants were excluded from the trial; 6. Myocardial infarction \<2 weeks or unstable angina attack period; 7. Severe and uncontrolled arrhythmia; 8. Acute heart failure stage; 9. Severe and symptomatic obstruction of the outflow tract; 10. Acute deep vein thrombosis with or without pulmonary embolism; 11. Acute myocarditis, pericarditis or endocarditis; 12. Acute aortic dissection; 13. Intracardiac thrombus with high risk of embolism; 14. Massive pericardial effusion; 15. Those who fail to exercise adequately or refuse to sign informed consent.
๐Ÿ’Š

What it tests

  • Moderate-intensity continuous movement and Antipsychotics intervention
  • Antipsychotics intervention(sertraline, escitalopram, fluoxetine, duloxetine, paroxetine, venlafaxine, and fluvoxamine)
๐Ÿ“

Where

1 site
Guangdong Provincial People's Hospital
Guangzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy